Title II · Study
MPJE pharmacist practice: the largest area of the exam, topic by topic
Pharmacist Practice is Area 2 of the MPJE® (Multistate Pharmacy Jurisprudence Examination) and its largest: 33% of the scored questions under NABP's Competency Statements, the outline that applies to every MPJE taken through February 28, 2027. It covers what a valid prescription looks like, how often it may be refilled, the offer to counsel, taking drugs back, and patient privacy. Below, each topic gets its federal anchor with a citation, and a flag wherever your state writes its own rule.
Checked against NABP and federal sources on October 19, 2026.
§ 1 What Area 2 covers on NABP's current outline
33%
of scored questions
NABP Competency Statements, exams through Feb 28, 2027
about 33
of 100 scored items
Our arithmetic: NABP publishes the percentage only
5
competency statements
Numbered 2.1 to 2.5
The exam has 120 questions, of which 100 are scored and 20 are unmarked pretest items spread through the test. Area 2 therefore decides roughly a third of your result, more than Licensure/Personnel (22%), Dispensing Requirements (24%) or Pharmacy Operations (21%).
| Statement | What it asks you to know | Federal anchor |
|---|---|---|
| 2.1 Issuing prescriptions | Who may prescribe, what a valid order must contain, drug-use and refill limits for controlled and non-controlled drugs | 21 CFR 1306; FD&C Act §503(b), 21 U.S.C. 353(b) |
| 2.2 Drug administration | Giving drugs as part of managing a patient's therapy | Vaccine records, 42 U.S.C. 300aa-25; scope is state law |
| 2.3 Counseling | The offer to counsel, what counseling covers, how it is documented | OBRA-90, 42 CFR 456.705(c); 21 CFR 208, 209 |
| 2.4 Returning and reusing drugs | When a dispensed drug may come back, and what happens to it | DEA collectors, 21 CFR 1317 |
| 2.5 Practice regulations | Quality and safety of practice; confidentiality of patient and health records | HIPAA Privacy Rule, 45 CFR 164 |
Source: NABP MPJE Competency Statements, checked October 19, 2026
From March 1, 2027: where the Area 2 topics move
Exams on or after March 1, 2027 follow NABP's new MPJE Content Outline: four different domains, weighted 30/30/20/20, none of them called Pharmacist Practice. The topics are regrouped, mostly into Medication Use Process. The mapping below is our reading of the two NABP documents.
| Area 2 statement | 2027 domain | 2027 line |
|---|---|---|
| 2.1 Issuing prescriptions | 2 Medication Use Process (30%) | Issuing prescriptions, including validity, changes and emergency prescriptions; fills and refills |
| 2.2 Drug administration | 2 Medication Use Process (30%) | Administration of medications, including training and adverse-event reporting |
| 2.3 Counseling | 2 Medication Use Process (30%) | Counseling, under dispensing |
| 2.4 Returns and reuse | 2 Medication Use Process (30%) | Recalls, returns and reuse, including drug repository programs |
| 2.5 Practice regulations | 1 Pharmacy and Pharmacist Practice (30%) | Regulatory standards; security of patient health information |
Source: NABP MPJE Content Outline (exams from March 1, 2027), checked October 19, 2026
§ 2 High-yield topics, statement by statement
2.1 What makes a prescription valid
Federally, a controlled-substance prescription must be dated and signed on the day it is issued and carry the patient's full name and address, the drug name, strength, dosage form, quantity, directions, and the prescriber's name, address and DEA registration number (21 CFR 1306.05(a)). An electronic one counts only if it is created and signed in an application that meets 21 CFR part 1311.
Schedule II has the tightest form rule. A pharmacist may dispense it on a written prescription signed by the practitioner or a compliant electronic one; a fax of a paper CII is a preview until the signed original is presented, with three narrow exceptions (21 CFR 1306.11(a)). An oral CII order is lawful only in an emergency, and then the prescriber has 7 days to deliver the written prescription marked “Authorization for Emergency Dispensing” (21 CFR 1306.11(d)). If it never arrives, the pharmacist must notify the nearest DEA office.
Non-controlled drugs run on the FD&C Act. A legend drug may be dispensed on a written prescription, or on an oral one that the pharmacist reduces promptly to writing and files, and refilled only as the prescriber authorizes (21 U.S.C. 353(b)(1)). Dispensing outside those routes makes the drug misbranded.
| Drug class | Federal refill rule | Citation | Commonly set by states |
|---|---|---|---|
| Schedule II | No refills. A prescriber may issue several prescriptions totalling up to a 90-day supply, each after the first with its earliest fill date, if state law permits | 21 CFR 1306.12 | Whether multiple CII prescriptions are allowed; how long a CII prescription stays valid |
| Schedules III and IV | No fill or refill more than 6 months after issue; no more than 5 refills | 21 CFR 1306.22(a) | Shorter validity periods; quantity limits |
| Schedule V | Outside the 5-refill, 6-month cap, which names Schedules III and IV only | 21 CFR 1306.22(a) | Refill limits and expiry |
| Non-controlled | Refills only as the prescriber authorizes; no federal count or expiry | 21 U.S.C. 353(b)(1) | Expiry of the prescription; emergency supplies of maintenance drugs |
Source: eCFR, 21 CFR part 1306; 21 U.S.C. 353, checked October 19, 2026
2.2 Administering drugs and vaccines
Whether a pharmacist may immunize, at what patient age, under which protocol, and whether a collaborative practice agreement can let you start or change therapy are all state questions. Federal law adds one recordkeeping duty that applies everywhere: for any vaccine on the Vaccine Injury Table, the provider who gives it records four things in the patient's permanent record (42 U.S.C. 300aa-25(a)).
- Date the vaccine was given
- Manufacturer and lot number
- Name, address and, where appropriate, title of the person who gave it
- Any other identifying information HHS requires by regulation
2.3 The offer to counsel
OBRA-90 made each state set counseling standards as a condition of Medicaid drug coverage. The federal rule requires an offer to counsel every Medicaid patient or caregiver who presents a prescription, in person whenever practicable or through a toll-free telephone line; mail-order pharmacies must provide that toll-free line (42 CFR 456.705(c)(2)). A pharmacist need not counsel a patient who refuses, but the state must say how the refusal is documented. Nearly every state then extended its standard beyond Medicaid patients, which is why you study it as a general rule.
- New or refill
- The state decides whether the offer is required for new prescriptions only or for refills too.
- Who makes the offer
- The state decides whether the pharmacist must make it or auxiliary staff may.
- Documentation
- The state decides whether only refusals are documented, or every offer, and whether counseling itself is recorded.
- Absent patient
- The state decides how delivered and mailed prescriptions are handled when no one is there to hear the offer.
The counseling itself covers whatever the pharmacist judges significant from eight matters listed in 42 CFR 456.705(c)(3): the drug's name and description; dosage form, dose, route and duration; special directions and precautions; common severe side effects, interactions and contraindications and what to do about them; self-monitoring; storage; refill information; and what to do after a missed dose.
2.4 Returned drugs
Once a drug leaves the pharmacy, nobody can vouch for how it was stored, so the usual multistate principle is that it does not go back into stock for another patient. States carve out narrow exceptions, such as sealed unit-dose packages from long-term care facilities or drug repository and donation programs, and those exceptions are yours to look up. Controlled substances returned by a patient are a federal matter: a retail pharmacy may take them only after modifying its DEA registration to become an authorized collector, and the collected drugs never re-enter inventory (21 CFR 1317.40).
2.5 Patient privacy under HIPAA
Privacy is where our Area 2 cases cluster. The federal rule is the same in every state, and state law may add protection on top. Four disclosures come up again and again:
| Situation | What the Privacy Rule allows | Citation |
|---|---|---|
| Calling another provider about the patient's therapy | Allowed without authorization: it is treatment | 45 CFR 164.506(c) |
| A relative asks about, or picks up, the patient's prescription | Patient present: they agree or do not object. Patient absent: professional judgment of their best interest, which expressly covers picking up filled prescriptions | 45 CFR 164.510(b) |
| Police ask for records | Allowed in response to a court order, court-ordered warrant, judicial or grand jury subpoena, or an administrative request the law requires you to answer, limited to what is asked | 45 CFR 164.512(f)(1) |
| The patient wants copies of their records | Act within 30 days, with one extension of up to 30 more days explained in writing; provide the requested format if readily producible; charge only a reasonable, cost-based fee | 45 CFR 164.524 |
Source: eCFR, 45 CFR part 164 subpart E, checked October 19, 2026
§ 3 Typical traps, taken from the explanations behind our cases
Each trap below is a wrong option that keeps appearing in our Area 2 cases, with the rule that defeats it.
Before you trust an option that quotes a number of days, ask whose number it is: DEA's, FDA's, CMS's or your board's.
§ 4 The federal versus state angle in this area
Area 2 mixes both layers more than any other area. Federal law fixes the controlled-substance prescription, the Medicaid counseling framework and HIPAA; almost everything about daily practice scope is state law. Sorting each fact into its layer is the fastest way to study it.
Set by federal law
- Schedule II: no refills; emergency oral order with a 7-day follow-up
- Schedules III and IV: 6 months and 5 refills at most
- Contents of a controlled-substance prescription
- Medicaid offer to counsel and its eight topics
- Medication Guides and the side-effects statement
- HIPAA disclosures and the 30-day access rule
Set by your state
- How long any prescription stays valid
- Who may make the offer to counsel, and for refills or not
- Pharmacist immunization authority and age limits
- Collaborative practice and pharmacist prescribing
- Emergency refills of non-controlled drugs
- Taking back non-controlled drugs; repository programs
The tell If the federal rule is silent or says “as state law permits”, the state MPJE will test your state's version.
If your board has adopted the Uniform MPJE (UMPJE), the balance shifts: NABP describes it as testing principles of state law that are uniform across jurisdictions, alongside federal law. Which exam your board uses is on our state-by-state exam page; the differences are on the UMPJE page.
§ 5 Practice cases for Area 2
The twelve cases below are all from Area 2: issuing prescriptions, counseling, HIPAA privacy and vaccine records. Each is tagged Federal rule or Multistate principle, and none tests a single state's law. The full mixed set of 60 across all four areas is on the practice questions page, and the controlled-substance dispensing rules have their own page on federal pharmacy law.
Casebook · 12 cases · free, no sign-up
12 cases to try now
0 of 12 answered · 0 correct
Under federal rules, when may a pharmacy dispense a Schedule II drug from an electronic prescription?
Choose A, B, C or D. The ruling lands here: verdict, reasoning, then each option annotated.
Keys: A–D answer · N next · P back
Docket closed
Docket
§ 6 Where to go next
§ 7 Questions candidates ask
What percentage of the MPJE is pharmacist practice?
33% of the scored questions, about 33 of the 100 that count, under NABP's Competency Statements for exams through February 28, 2027. From March 1, 2027 the new MPJE Content Outline drops the Pharmacist Practice area and spreads its topics across Medication Use Process (30%) and Pharmacy and Pharmacist Practice (30%).
Does the MPJE test federal or state rules on counseling?
Both, graded by your state. OBRA-90 requires an offer to counsel Medicaid patients, but each state decides who makes the offer, whether refills are included and how refusals are recorded. On a state MPJE, your state's version is the correct answer.
Will a failing MPJE report show how I did in pharmacist practice?
Yes, in relative terms. NABP reports pass or fail only, with no score, and a failing report shows your relative performance in each of the four competency areas. That tells you whether Area 2 is where the 30-day wait before a retake should go.
Is pharmacist practice tested on the Uniform MPJE (UMPJE)?
The UMPJE outline has no area by that name. It uses the same four domains and weights as the 2027 MPJE outline, and prescriptions, counseling, returns and privacy appear inside them. See the UMPJE page for which boards use it.